In brief
President Donald Trump is set to meet Colombian President Gustavo Petro at the White House, following a series of controversial statements regarding Colombia and Venezuela. Amid heightened tensions due to a recent military operation against Venezuela, Trump praised Petro's communication style while also warning him about drug trafficking issues. This meeting marks a significant diplomatic moment as both leaders navigate complex relations in the drug trade and regional stability.
US President Donald Trump has confirmed he will hold a meeting with Colombian President Gustavo Petro at the White House in the 'near future'. This announcement follows Trump's recent remarks expressing support for an operation aimed at Colombia, coinciding with escalating tensions involving Venezuela.
In a statement, Trump indicated that during a phone conversation with Petro, they discussed the serious issues surrounding drug trafficking and other disputes. The US president particularly appreciated Petro’s approach during their discussions, calling it a 'Great Honor'.
The backdrop to this meeting includes a significant US military operation in Venezuela that resulted in the capture of President Nicolás Maduro. This operation has drawn attention for its high death toll and raises questions about US intervention in the region.
Petro has expressed concerns about Colombia's position in the ongoing drug trade, considering the country's reputation as a major cocaine producer. The President of Colombia firmly defended his administration's efforts against drug trafficking, despite facing criticisms and sanctions from the US.
Following the recent military actions, Trump made derogatory remarks about Petro, suggesting his administration was failing to control drug production in Colombia. In response, Petro has warned that any violent actions against Colombia could provoke a strong response from his government.
The meeting between the two leaders might set the stage for future cooperation amidst a climate of tension and potential disagreements over drug policy and military interventions.
